A predominant expression of IDO1 in the tumor endothelial cell fraction was also noted in HCmel12 melanomas, but the level of IDO1 and of intratumoral IFNγ were not significantly increased by anti-CD40 therapy in this model (Supplementary Fig S3A-D). The gene discussed is IFNG; the disease is melanoma.